Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A living ex vivo platform for functional, personalized brain cancer diagnosis.
Mann B, Zhang X, Bell N, Adefolaju A, Thang M, Dasari R, Kanchi K, Valdivia A, Yang Y, Buckley A, Lettry V, Quinsey C, Rauf Y, Kram D, Cassidy N, Vaziri C, Corcoran DL, Rego S, Jiang Y, Graves LM, Dunn D, Floyd S, Baldwin A, Hingtgen S, Satterlee AB. Mann B, et al. Among authors: vaziri c. Cell Rep Med. 2023 Jun 20;4(6):101042. doi: 10.1016/j.xcrm.2023.101042. Epub 2023 May 15. Cell Rep Med. 2023. PMID: 37192626 Free PMC article.
Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Cheng X, An J, Lou J, Gu Q, Ding W, Droby G, Wang Y, Wang C, Gao Y, Shelton A, Satterlee AB, Mann BE, Hsiao YC, Liu CW, Liu K, Hingtgen S, Wang J, Liu Z, Miller R, Wu D, Vaziri C, Yang Y. Cheng X, et al. Among authors: vaziri c. Res Sq [Preprint]. 2023 Oct 16:rs.3.rs-2367368. doi: 10.21203/rs.3.rs-2367368/v1. Res Sq. 2023. PMID: 37886584 Free PMC article. Updated. Preprint.
Trans-Lesion Synthesis and Mismatch Repair Pathway Crosstalk Defines Chemoresistance and Hypermutation Mechanisms in Glioblastoma.
Cheng X, An J, Lou J, Gu Q, Ding W, Droby G, Wang Y, Wang C, Gao Y, Shelton A, Satterlee AB, Mann BE, Hsiao YC, Liu CW, Liu K, Hingtgen S, Wang J, Liu Z, Miller R, Wu D, Vaziri C, Yang Y. Cheng X, et al. Among authors: vaziri c. bioRxiv [Preprint]. 2023 Oct 19:2023.10.16.562506. doi: 10.1101/2023.10.16.562506. bioRxiv. 2023. PMID: 37905107 Free PMC article. Updated. Preprint.
REV7-p53 interaction inhibits ATM-mediated DNA damage signaling.
Biller M, Kabir S, Boado C, Nipper S, Saffa A, Tal A, Allen S, Sasanuma H, Dréau D, Vaziri C, Tomida J. Biller M, et al. Among authors: vaziri c. Cell Cycle. 2024 Feb;23(4):339-352. doi: 10.1080/15384101.2024.2333227. Epub 2024 Apr 1. Cell Cycle. 2024. PMID: 38557443
Identification of Covalent Cyclic Peptide Inhibitors in mRNA Display.
Iskandar SE, Chiou LF, Leisner TM, Shell DJ, Norris-Drouin JL, Vaziri C, Pearce KH, Bowers AA. Iskandar SE, et al. Among authors: vaziri c. J Am Chem Soc. 2023 Jul 19;145(28):15065-15070. doi: 10.1021/jacs.3c04833. Epub 2023 Jul 3. J Am Chem Soc. 2023. PMID: 37395736
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma.
Cheng X, An J, Lou J, Gu Q, Ding W, Droby GN, Wang Y, Wang C, Gao Y, Anand JR, Shelton A, Satterlee AB, Mann B, Hsiao YC, Liu CW, Lu K, Hingtgen S, Wang J, Liu Z, Miller CR, Wu D, Vaziri C, Yang Y. Cheng X, et al. Among authors: vaziri c. Nat Commun. 2024 Mar 4;15(1):1957. doi: 10.1038/s41467-024-45979-5. Nat Commun. 2024. PMID: 38438348 Free PMC article.
86 results